- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03248986
Dry Needling in Stroke to Improve the Upper Limb Functionality
Effectiveness of Dry Needling in Improving the Functionality of the Affected Arm in the Patient With Stroke
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Once each patient has signed the informed consent document and it has been verified that the inclusion criteria are met, it will be assigned the same identification number (ID) that is related to its Clinical History (CH) by simple coding; custody of the file with the relationship of each ID with its CH will be the responsibility of the principal investigator.
Patients admitted to the Guadarrama Hospital with the diagnosis of stroke and who meet the eligibility criteria will be treated by their usual physiotherapist, who will administer the standard dry needling intervention.
Patients will receive 6 sessions of DNHS® technique with an interval of 1 week between each session (1st to 4th sessions) and every 15 days (5th and 6th sessions). The procedure will be applied according to the corresponding protocols established in the NWPs (Normalized Work Plans) used in the usual clinical practice in the Guadarrama Hospital.
The DNHS® technique is specifically indicated for the treatment of spasticity. This technique differs from that usually used to relieve pain and deactivate myofascial trigger points (MTPs). The muscles to be treated are placed in a submaximum stretching position; the evaluation criteria when defining the needle insertion zone are based on finding an increase in modularity and muscle activity in the area when the muscle undergoes rapid stretching. Once the area to be treated is located, the needle is inserted and moves between 0.5 and 1 cm in / deep and fan out / surface to cause a local or global spasm reaction. Treatment ceases when the frequency of these responses decreases markedly or disappears. If the patient feels "not tolerable" pain (some discomfort from the dry needling is usual), you can stop the treatment at any time.
Before and after each dry needling session patients will be evaluated by their usual physiotherapist, using the upper limb block of the Fugl-Meyer scale that assesses motor skills and sensitivity of the affected arm, evaluation of pain through NRS10 and assessment of spasticity of muscles to be treated by MMAS. Also, at the beginning, in the 4th session and at the end of the study, the Euro-QoL 5D-5L quality of life survey will be administered, with a license for use. In adition BSS and ULP will be evaluated at the begining and at the end of the study. In each dry needling session, the caliber of the needle used, the number of fast-in and fast-out of the needle and the number of the spasm reactions caused for the purpose of establishing the dose pattern shall be recorded for each treated muscle.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Madrid
-
Guadarrama, Madrid, Spania, 28440
- J.Nicolas Cuenca Zaldivar
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- They must voluntarily understand and sign the relevant informed consent documents and information sheet, before any evaluation / procedure related to the study is conducted.
- Male or female, ≥ 18 years old at the time of consent.
- Have the diagnosis of hemispheric ischemic or hemorrhagic stroke without excluding other causes (surgical, traumatic, etc ...).
- Show spasticity in the affected upper limb, with an MMAS score of 1-3 in one of the following muscle groups: finger flexors, wrist flexors, elbow flexors, forearm pronators, adductors, or internal rotators of the shoulder.
Exclusion Criteria:
- Presence of stiffness (score of 4 in MMAS) or hypotonia (MMAS of 0).
- Severe cognitive impairment, severe language problems, severe vision or hearing impairments that prevent compression and active patient collaboration during evaluation tests.
- Have received treatment by injection of TBA in the 2 months prior to the start of the study.
- Any medical condition that contraindicates dry needling.
- Present some contraindication for the application of dry puncture: Pregnancy, insurmountable fear of needles, allergy to metals (nickel), presence of lesions in the puncture area, scars, tattoos...
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Fugl-Meyer Upper Limb Scale.
Tidsramme: 8 weeks
|
Evaluation of the functionality of the affected arm
|
8 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Modification of Modified Ashworth Scale
Tidsramme: 8 weeks
|
Assessment of spasticity
|
8 weeks
|
Euro QoL 5D quality of life scale
Tidsramme: 8 weeks
|
Quiality of life evaluation
|
8 weeks
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Numerical Rating Scale 10-points scale
Tidsramme: 8 weeks
|
Pain evaluation
|
8 weeks
|
Brunnstrom Recovery Stages
Tidsramme: 8 weeks
|
Upper limb motor recovery.
|
8 weeks
|
Upper limb pattern
Tidsramme: 8 weeks
|
Upper limb spastic pattern.
|
8 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 1.0
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Livskvalitet
-
Marlene FischerFullførtPostoperativ Quality of Recovery i Postanesthesia Care UnitTyskland
-
Anqing Municipal HospitalFullførtDexmedetomidin | Lidokain | Quality of Recovery (QoR-40), Preoperativ og PostoperativKina
-
University Hospital, GrenobleUkjentHealth Care Quality Management (ingen betingelse).Frankrike
-
Prisma Health-UpstateNational Institute on Drug Abuse (NIDA); Clemson UniversityRekrutteringVelferdstandard | Standard of Care + CBT4CBT | Standard of Care + CBT4CBT + RCForente stater
-
Sorbonne UniversityAalborg UniversityRekrutteringPoint of Care UltralydFrankrike
-
Imperial College LondonFullført
-
Asociacion Española Primera en SaludIntensive Care Unit Pasteur HospitalFullførtPoint of Care UltralydUruguay
-
Aga Khan UniversityThe Hospital for Sick Children; Grand Challenges CanadaUkjentPoint of Care UltralydPakistan
-
Research Unit Of General Practice, CopenhagenUniversity of Copenhagen; Region Capital Denmark; The Copenhagen General... og andre samarbeidspartnereFullført
-
Nimble Science Ltd.University of Calgary; Lallemand Health SolutionsFullført
Kliniske studier på Dry needling
-
Brigham Young UniversityAvsluttetMyofascial smertesyndrom | Myofascial triggerpunktsmerteForente stater
-
Universidad de ZaragozaFullført
-
Institute of Technology, CarlowFullført
-
Universidad de ZaragozaUkjent
-
Universitat Internacional de CatalunyaRekrutteringMyofascial triggerpunktsmerteSpania
-
University of HaifaFullførtSmerte i korsryggenIsrael
-
Kutahya Health Sciences UniversityHar ikke rekruttert ennå
-
University of Castilla-La ManchaFullførtTriggerpunktsmerte, MyofascialSpania
-
Duke UniversityPåmelding etter invitasjonSkuldersmerte | Frossen skulder | Skulderklebende kapsulittForente stater
-
Kutahya Health Sciences UniversityHar ikke rekruttert ennåMyofascial triggerpunktsmerte